Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal

類似資料

• Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.
  著者:: Latimer, N, 等
  出版事項: (2014)
• Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
  著者:: Guerry, M, 等
  出版事項: (2012)
• Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
  著者:: Flossmann, O, 等
  出版事項: (2006)
• Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis
  著者:: Michael A Paley, 等
  出版事項: (2019-01-01)
• Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
  著者:: Robson, J, 等
  出版事項: (2017)